$KMB

Kimberly-Clark (KMB) Q2 2026 Earnings Call Transcript

Kimberly-Clark (KMB) reported Q2 2026 net sales of $4.2B, up 0.6% on currency gains, while adjusted EPS from continuing operations rose 10.4% to $1.80. Adjusted gross margin increased to 38.8%. Management cited $45M tariff refunds, China social media disruption, and a $22M LA distribution center fire. Full-year organic sales guidance is about 100 bps below category growth; adjusted EPS guidance calls for high-single-digit constant-currency growth.

Original reporting
Published Aug 11, 2026, 5:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 6:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Kimberly-Clark (KMB) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$KMBNeutralMed
01

Why it matters

Traders can update models using the call’s explicit quarterly metrics (net sales, adjusted EPS, gross margin), quantified 2H headwinds (China operating profit headwind ~$70M, input cost headwinds ~$150M), and full-year guidance direction (organic sales about 100 bps below category growth; adjusted EPS high single digits constant currency). It also reiterates the Kenvue acquisition integration plan and targeted $1.9B cost synergies.

02

Market read

The call contains multiple quantified items that can re-anchor expectations for margins, organic sales trajectory, and 2H 2026 earnings, with additional M&A execution context via the Kenvue transaction.

03

What to watch

Higher marketing and transformation costs (SG&A up to $1.0B) and sharply higher capex in 1H 2026 ($776M) could pressure near-term free cash flow, even if adjusted operating profit is guided to grow mid-single digits constant currency.

Relevance 8/10Novelty 8/10Timing: post-call, for positioning ahead of next earnings/guidance revisions

Background

The article is a transcript of Kimberly-Clark’s Q2 2026 earnings call, covering results, transformation initiatives, quantified regional disruptions, and full-year guidance.

Company-level read

Ticker impact

$KMBNeutralMedium confidence
Context

Kimberly-Clark reported Q2 net sales of $4.2B, raised adjusted EPS to $1.80, and guided full-year organic sales and adjusted EPS growth amid China and tariff impacts.

Expected impact

Near-term volatility likely as traders weigh raised adjusted EPS growth (high single digits constant currency) against full-year organic sales guidance running about 100 bps below category growth and a ~$70M H2 China operating profit headwind.

Evidence & confidence

The transcript includes multiple decision-relevant datapoints: quarterly results, full-year guidance ranges/direction, and explicit quantified headwinds/tailwinds for 2H 2026, which can re-anchor expectations and positioning.

Market effects

Highlights ongoing consumer staples margin sensitivity to tariffs, input costs (oil-linked), and brand investment levels, which can influence read-across for packaged hygiene/personal care peers.

China social media disruption is quantified as a 50 bps quarterly and ~100 bps full-year headwind, signaling elevated brand/reputation risk in that region.

Tariff refund benefit ($45M) and productivity savings (6.4% gross productivity) underscore how policy and operational execution can swing reported margins even with modest top-line growth.

Counterpoint

Despite organic sales softness, management frames underlying brand fundamentals as stable with sustained volume-plus-mix growth for 10 consecutive quarters, suggesting the market may over-discount the China disruption if it proves contained.

Key entities

  • Kimberly-Clark

    Reported Q2 2026 results and provided full-year guidance, including quantified China disruption and tariff refund benefits, plus Kenvue acquisition integration updates.

  • Kenvue

    Acquisition target referenced as expected to close by end of 2026, with integration planning ahead of expectations and synergy targets discussed.

  • Arbex joint venture

    Referenced as completed, tied to the Powering Care transformation strategy.

Related articles

$KMBMedAI 8/10

KMB Cuts 2026 Outlook as China Diaper Disruption Clouds Growth View

Kimberly-Clark (KMB) cut its 2026 outlook after a China social-media disruption hurt diaper sales. Management estimates the disruption will affect 2026 by about 100 bps, lowering consolidated Q2 organic sales growth by ~50 bps and creating an International Personal Care headwind of ~140 bps and ~440 bps operating profit drag. Adjusted operating profit rose 6.2% to $757M and EPS rose 10.4% to $1.80.

$KMBMed

KMB Q2 Earnings Call Focuses on China Risk, 2026 Outlook Cut

Kimberly-Clark (KMB) said its Q2 2026 outlook was cut due to a China diaper disruption, North American trade inventory reductions, and softer category growth. Adjusted EPS was $1.80 vs $2.00 expected, and net sales were $4.19B vs $4.23B. Management expects China to create about a 200 bps sales headwind in H2 and $70M operating profit pressure.

$KMBMed

Kimberly-Clark to Consolidate Operations, Invest in Digital Optimizations Ahead of Kenvue Acquisition

Kimberly-Clark said it will consolidate 6,000 applications and more than 15 ERP systems as it nears completion of its Kenvue acquisition. On an earnings call, COO Russell Torres cited a three-year plan targeting $1.9 million in savings and identified over $600 million of savings, with system integration and supply chain and commercial integration as key drivers.